Lung Injury Associated with Bortezomib Therapy in Relapsed/Refractory Multiple Myeloma in Japan : A Questionnaire-Based Report from the "Lung Injury by Bortezomib" Joint Committee of the Japanese Society of Hematology and the Japanese Society of Clinical
スポンサーリンク
概要
- 論文の詳細を見る
- 2006-12-15
著者
-
Usubuchi Noriko
国立がんセンター中央病院
-
Usubuchi Noriko
Hematology And Oncology Division National Cancer Center Hospital East
-
Hotta Tomomitsu
国立がんセンター中央病院 血液内科
-
Hotta Tomomitsu
東海大学 医学研究科血液腫瘍内科
-
Uike Naokuni
Department Of Hematology National Kyushu Cancer Center Hospital
-
Uike N
National Kyusyu Cancer Center
-
DAN Kazuo
Division of Hematology, Department of Internal Medicine, Nippon Medical School
-
Usui Noriko
東京慈恵会医科大学附属病院 中央検査部
-
Usui N
Division Of Hematology And Oncology Department Of Medicine Jikei University
-
Usui Noriko
Jikei University Hospital
-
Ohnishi Kazunori
東北大学病院 血液･免疫科
-
Usui N
Jikei University Hospital
-
Hotta T
National Hospital Organization Nagoya Medical Center
-
Oshimi Kazuo
Division Of Hematology Department Of Internal Medicine Juntendo University School Of Medicine
-
Ikeda Y
Division Of Hematology Department Of Medicine Keio University School Of Medicine
-
Oshimi Kazuo
Division Of Hematology Department Of Medicine Juntendo University School Of Medicine
-
Uike Naokuni
Department Of Hemato-oncology Kyushu Cancer Center
-
Dan K
Department Of Hematology Nippon Medical School
-
Dan Kazuo
Division Of Hematology Department Of Medicine Nippon Medical School
-
Ikeda Y
Department Of Medicine School Of Medicine Keio University
-
Oshimi Kazuo
Department Of Hematology Juntendo University Tokyo
-
Usui Noriko
Department Of Hematology The Jikei University
-
Usui Noriko
The "lung Injury By Bortezomib" Joint Committee Of The Japanese Society Of Hematology And
-
Oshimi Kazuo
Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Hata Tomoko
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Iwao Yasushi
Department Of Internal Medicine Division Of Gastroenterology And Hepatology Keio University School O
-
GOTOH Akihiko
The "Lung Injury by Bortezomib" Joint Committee of the Japanese Society of Hematology and the Japane
-
OHYASHIKI Kazuma
The "Lung Injury by Bortezomib" Joint Committee of the Japanese Society of Hematology and the Japane
-
OSHIMI Kazuo
The "Lung Injury by Bortezomib" Joint Committee of the Japanese Society of Hematology and the Japane
-
USUI Noriko
The "Lung Injury by Bortezomib" Joint Committee of the Japanese Society of Hematology and the Japane
-
HOTTA Tomomitsu
The "Lung Injury by Bortezomib" Joint Committee of the Japanese Society of Hematology and the Japane
-
DAN Kazuo
The "Lung Injury by Bortezomib" Joint Committee of the Japanese Society of Hematology and the Japane
-
IKEDA Yasuo
The "Lung Injury by Bortezomib" Joint Committee of the Japanese Society of Hematology and the Japane
-
Ikeda Yasuo
The "lung Injury By Bortezomib" Joint Committee Of The Japanese Society Of Hematology And
-
Ohnishi Kazunori
Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Ida Yosuke
Department Of Internal Medicine School Of Medicine Keio University
-
Omachi Ken
Department Of Hematology And Oncology Tokai University School Of Medicine
-
Ochi Kensuke
Laboratory Of Molecular Medicine Human Genome Center Institute Of Medical Science University Of Toky
-
Dan Kazuo
Department Of Internal Medicine Nippon Medical School
-
Usui Noriko
Division Of Oncology & Hematology Department Of Internal Medicine The Jikei University School Of
-
Gotoh Akihiko
The "lung Injury By Bortezomib" Joint Committee Of The Japanese Society Of Hematology And
-
Ohnishi Kazunori
The Department Of Medicine Iii Hamamatsu University School Of Medicine
-
Hotta Tomomitsu
The "lung Injury By Bortezomib" Joint Committee Of The Japanese Society Of Hematology And
-
Hotta Tomomitsu
The "lung Injury By Bortezomib" Joint Committee Of The Japanese Society Of Hematology And
関連論文
- Serial monitoring of T315I BCR-ABL mutation by Invader assay combined with RT-PCR
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan : a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- Use of Octreotide in the Management of Severe Duodenal Bleeding after Unrelated-Donor Bone Marrow Transplantation
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- Molecular monitoring of BAALC expression in patients with CD34-positive acute leukemia
- Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Elevated serum levels of human matrix metalloproteinase-9 (MMP-9) during the induction of peripheral blood stem cell mobilization by granulocyte colony-stimulating factor (G-CSF)
- Intensifying Daunorubicin in Induction for Patients with Core Binding Factor Leukemia
- Intensified Daunorubicin in Induction Therapy and Autologous Peripheral Blood Stem Cell Transplantation in Postremission Therapy (Double-7 Protocol) for Adult Acute Myeloid Leukemia
- Severe Aplastic Anemia Associated With Chronic Natural Killer Cell Lymphocytosis
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
- Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate (^Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma
- Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas : Results of a Japanese Phase II Study
- Philadelphia Chromosome-Positive Acute Myeloid Leukemia With Tetraploidy
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Early cytomegalovirus (CMV) gastrointestinal disease that developed 19 days after bone marrow transplantation, with a high-level of CMV antigenemia, of up to 1120 cells/slide
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
- Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia : Study of the Japan Adult Leukemia Study Group (JALSG)
- Phase II Study of Cladribine(2-Chlorodeoxyadenosine) in Relapsed or Refractory Adult T-Cell Leukemia-Lymphoma
- Case-control study of leukemia and diagnostic radiation exposure
- Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma : A Japan Clinical Oncology Group Study, JCOG 9301
- Therapy-Related Leukemia and Myelodysplastic Syndrome: A Large-scale Japanese Study of Clinical and Cytogenetic Features as Well as Prognostic Factors
- Successful cord blood transplantation for mycosis fungoides.
- Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
- Multicenter Prospective Study of Clonal Complications in Adult Aplastic Anemia Patients following Recombinant Human Granulocyte Colony-Stimulating Factor (Lenograstim) Administration
- Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma
- Morphological spectrum of cyclin D1-positive mantle cell lymphoma : Study of 168 cases
- Expression of Human Tumor-Associated Antigen RCAS1 in Adult T-Cell Leukemia/Lymphoma
- Pulmonary non-caseating granuloma in Waldenstrom macroglobulinemia
- Adhesion-dependent growth of primary adult T cell leukemia cells with down-regulation of HTLV-I p40Tax protein : a novel in vitro model of the growth of acute ATL cells
- Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
- Prognostic Significance of FLT3 Internal Tandem Duplication and NPM1 Mutations in Acute Myeloid Leukemia in an Unselected Patient Population
- Phase II study of chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia or lymphoblastic lymphoma : Japan Clinical Oncology Group study 9004
- A Phase II Study of VEPA/FEPP Chemotherapy for Aggressive Lymphoma in Elderly Patients : Japan Clinical Oncology Group Study JCOG9203
- A Randomized Controlled Trial Investigating the Survival Benefit of Dose-Intensified Multidrug Combination Chemotherapy (LSG9) for Intermediate- or High-Grade Non-Hodgkin's Lymphoma : Japan Clinical Oncology Group Study 9002
- Multicenter Prospective Study of Interferon α versus Allogeneic Stem Cell Transplantation for Patients with New Diagnoses of Chronic Myelogenous Leukemia
- Deoxycoformycin-Containing Combination Chemotherapy for Adult T-Cell Leukemia-Lymphoma : Japan Clinical Oncology Group Study (JCOG9109)
- Possible Attenuation of Fas-Mediated Signaling by Dominant Expression of Caspase-8 Aberrant Isoform in Adult T-Cell Leukemia Cells
- Adult T-Cell Leukemia-Lymphoma Successfully Treated with 2-Chlorodeoxyadenosine
- Combination Chemotherapy With Risk Factor-Adjusted Dose Attenuation for High-Risk Myelodysplastic Syndrome and Resulting Leukemia in the Multicenter Study of the Japan Adult Leukemia Study Group (JALSG): Results of an Interim Analysis
- Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
- Oncogene Associated cDNA Microarray Analysis Shows PRAME Gene Expression is a Marker for Response to Anthracycline Containing Chemotherapy in Patients with Diffuse Large B-cell Lymphoma
- Peripheral neuropathy caused by high-dose cytosine arabinoside treatment in a patient with acute myeloid leukemia
- A safety, pharmacokinetic and pharmacodynamic investigation of deferasirox (Exjade^【○!R】, ICL670) in patients with transfusion-dependent anemias and iron-overload : a Phase I study in Japan
- Lung Injury Associated with Bortezomib Therapy in Relapsed/Refractory Multiple Myeloma in Japan : A Questionnaire-Based Report from the "Lung Injury by Bortezomib" Joint Committee of the Japanese Society of Hematology and the Japanese Society of Clinical
- Successful Combination Therapy with Trastuzumab and Paclitaxel for Adriamycin- and Docetaxel-Resistant Inflammatory Breast Cancer
- Relationship between morphological classification of the degree of maturation and the ploidy of micromegakaryocytes in myelodysplastic syndrome patients
- Gene Expression of Erythropoietin in Renal Cell Carcinoma
- Clinical Effects of Infusing Anti-Epstein -Barr Virus (EBV)-Specific Cytotoxic T-Lymphocytes into Patients with Severe Chronic Active EBV Infection
- Comparison of Soluble and Membrane Bound HLA-Class I and DR Levels in Umbilical Cord Blood and Adult Peripheral Blood
- The Generation of Immunocompetent Dendritic Cells From CD34^+ Acute Myeloid or Lymphoid Leukemia Cells
- Ex Vivo Expansion of Human Cord Blood Stem Cells and Its Application to Gene Therapy
- Autografting with peripheral blood CD34-positive cells following high-dose chemotherapy against breast cancer
- Acquired hemophilia A may be associated with itraconazole
- Simultaneous Novel BCR-ABL Gene Mutation and Increased Expression of BCR-ABL mRNA Caused Clinical Resistance to STI571 in Double-Ph-Positive Acute Biphenotypic Leukemia
- Carcinoembryonic Antigen-Producing Multiple Myeloma Detected by a Transcription-Reverse Transcription Concerted Reaction System
- Toxicity and Outcome of Intensive Chemotherapy for Acute Lymphoblastic Leukemia Complicated with Turner's Syndrome
- CD2^+ Tetraploid Acute Promyelocytic Leukemia Variant with Double (15 ; 17) Translocations
- Septic Intramuscular Embolism in a Neutropenic Patient with Myelodysplastic Syndrome Accompanied by Asymptomatic Septic Pulmonary Emboli
- Th1/Th2 Lymphocyte Balance in Patients with Aplastic Anemia
- Successful Immunosuppressive Therapy with Cyclosporine A for Posthepatitis B-Cell Deficiency With Activated Cytoplasmic Interferon-γ-Positive T-Lymphocytes
- Renal vein lymphoma embolism in non-Hodgkin lymphoma
- Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era
- Alterations in the colorectal carcinoma gene and protein in a novel human myeloid leukemia cell line with trisomy 18 established from overt leukemia after myelodysplastic syndrome
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Pure White Cell Aplasia : Report of the First Case Associated with Primary Biliary Cirrhosis
- Oral Administration of Imatinib to P230 BCR/ABL-Expressing Transgenic Mice Changes Clones with High BCR/ABL Complementary DNA Expression into Those with Low Expression
- Small Cell Variant of T-Cell Prolymphocytic Leukemia with a γδ Immunophenotype
- Pseudo Gray Platelet Syndrome in a Patient with Acute Myocardial Infarction
- T-Cell Prolymphocytic Leukemia With Hemorrhagic Gastrointestinal Involvement and a New Chromosomal Abnormality
- Acute Lymphoblastic Leukemia with Isolated Adrenocorticotropic Hormone Deficiency
- Rationale and hematologic target points in response-oriented individualized induction chemotherapy for acute myeloid leukemia
- Herbal Medicine-Associated Lead Intoxication
- Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Two Cases of Mediastinal Gray Zone Lymphoma
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Bortezomib plus dexamethasone for relapsed or treatment refractory multiple myeloma : the collaborative study at six institutes in Kyoto and Osaka
- Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results
- Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Clinical efficacy and safety of biapenem for febrile neutropenia in patients with underlying hematopoietic diseases : a multi-institutional study
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- Expression of myeloperoxidase and gene mutations in AML patients with normal karyotype: double CEBPA mutations are associated with high percentage of MPO positivity in leukemic blasts.
- Rapid progression and unusual premortal diagnosis of mucormycosis in patients with hematologic malignancies : analysis of eight patients
- RCSD1-ABL1-positive B lymphoblastic leukemia is sensitive to dexamethasone and tyrosine kinase inhibitors and rapidly evolves clonally by chromosomal translocations
- Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa
- Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab : A multicenter phase II study
- Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Allogeneic hematopoietic stem cell transplantation for ATL with central nervous system involvement : The Nagasaki Transplant Group experience
- Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low-and low-intermediate risk, aggressive non-Hodgkin's lymphoma : final results of the Japan Clinical Oncology Group Study, JCOG95